Hopstem develops and commercializes CNS drugs and biomarkers for the treatment of neurological diseases.
Business Model:
Revenue: $0
Employees: 1-10
Address: No. 250, No. 6, Main Street
City: Hangzhou
State: zhejiang province
Zip: 310018
Country: CN
Hopstem develops and commercializes CNS drugs and biomarkers for the treatment of neurological diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2018 | Series A | - | 12/2018 | Series A | 1 | $2.9M |
Delta Capital Delta Capital |
5/2021 | Series A | 3 | - |
BioVenture Huacheng Venture Capital Longmen Capital BioVenture Huacheng Venture Capital Longmen Capital |
10/2021 | Series B | 2 | $40M |
BioVenture Lilly Asia Ventures BioVenture Lilly Asia Ventures |
12/2018 | Series A | - | 5/2021 | Series A | 3 | - |
BioVenture Huacheng Venture Capital Longmen Capital BioVenture Huacheng Venture Capital Longmen Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|